Biotech Richly Priced With One Exception
27 Nov, by in Uncategorized
At 10.3x book value and 50.3x cash flow on average, the biotech industry is among the most expensive in the MSCI World index. There have been some big winners in the biotech industry the last 4 years. Every stock in the industry has outperformed the...